Accueil › Colite ulcéreuse › Illinois › Chicago
Essais cliniques pour Colite ulcéreuse à Chicago, IL
15 études pour Colite ulcéreuse recherchent des participants dans et autour de Chicago (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Recrutement en coursPhase 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 2
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Recrutement en coursPhase 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Recrutement en coursPhase 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Recrutement en coursPhase 3
- Rush University Medical Center, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Recrutement en coursPhase 2
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Recrutement en coursPhase 2
- Northwestern University, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Recrutement en coursPhase 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Recrutement en cours
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Recrutement en coursÉtude observationnelle
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Recrutement en coursPhase 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Recrutement en coursPhase 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Recrutement en cours
- University of Chicago, Chicago
Essais pour Colite ulcéreuse dans d'autres villes
- New York City, NY24 études
- Orlando, FL23 études
- Miami, FL22 études
- Houston, TX18 études
- San Antonio, TX16 études
- Tacoma, WA15 études
- San Diego, CA15 études
- Colorado Springs, CO14 études
- St. Louis, MO14 études
- Tyler, TX14 études
- Los Angeles, CA13 études
- Boston, MA12 études
Autres études à Chicago
- Cancer du poumon non à petites cellules61 études
- Cancer du sein58 études
- Cancer (tous types)51 études
- Cancer de la prostate45 études
- Cancer métastatique45 études
- Obésité42 études
- Cancer du poumon41 études
- Cancer de l'ovaire36 études
- Accident vasculaire cérébral34 études
- Cancer colorectal32 études
- Insuffisance cardiaque31 études
- Surpoids28 études
Source : ClinicalTrials.gov, données récupérées le 2 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.